303 related articles for article (PubMed ID: 30996010)
1. Sicca Syndrome Associated with Immune Checkpoint Inhibitor Therapy.
Warner BM; Baer AN; Lipson EJ; Allen C; Hinrichs C; Rajan A; Pelayo E; Beach M; Gulley JL; Madan RA; Feliciano J; Grisius M; Long L; Powers A; Kleiner DE; Cappelli L; Alevizos I
Oncologist; 2019 Sep; 24(9):1259-1269. PubMed ID: 30996010
[TBL] [Abstract][Full Text] [Related]
2. Sicca/Sjögren's syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the International ImmunoCancer Registry (ICIR).
Ramos-Casals M; Maria A; Suárez-Almazor ME; Lambotte O; Fisher BA; Hernández-Molina G; Guilpain P; Pundole X; Flores-Chávez A; Baldini C; Bingham Iii CO; Brito-Zerón P; Gottenberg JE; Kostine M; Radstake TRD; Schaeverbeke T; Schulze-Koops H; Calabrese L; Khamashta MA; Mariette X;
Clin Exp Rheumatol; 2019; 37 Suppl 118(3):114-122. PubMed ID: 31464670
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab.
Cappelli LC; Gutierrez AK; Baer AN; Albayda J; Manno RL; Haque U; Lipson EJ; Bleich KB; Shah AA; Naidoo J; Brahmer JR; Le D; Bingham CO
Ann Rheum Dis; 2017 Jan; 76(1):43-50. PubMed ID: 27307501
[TBL] [Abstract][Full Text] [Related]
4. Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome?
Manthorpe R; Benoni C; Jacobsson L; Kirtava Z; Larsson A; Liedholm R; Nyhagen C; Tabery H; Theander E
Ann Rheum Dis; 2000 Jan; 59(1):54-60. PubMed ID: 10627428
[TBL] [Abstract][Full Text] [Related]
5. Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjögren's syndrome among 1,726 registry participants.
Daniels TE; Cox D; Shiboski CH; Schiødt M; Wu A; Lanfranchi H; Umehara H; Zhao Y; Challacombe S; Lam MY; De Souza Y; Schiødt J; Holm H; Bisio PA; Gandolfo MS; Sawaki T; Li M; Zhang W; Varghese-Jacob B; Ibsen P; Keszler A; Kurose N; Nojima T; Odell E; Criswell LA; Jordan R; Greenspan JS;
Arthritis Rheum; 2011 Jul; 63(7):2021-30. PubMed ID: 21480190
[TBL] [Abstract][Full Text] [Related]
6. A severe case of neuro-Sjögren's syndrome induced by pembrolizumab.
Ghosn J; Vicino A; Michielin O; Coukos G; Kuntzer T; Obeid M
J Immunother Cancer; 2018 Oct; 6(1):110. PubMed ID: 30348223
[TBL] [Abstract][Full Text] [Related]
7. Sicca syndrome following immune checkpoint inhibition.
Mavragani CP; Moutsopoulos HM
Clin Immunol; 2020 Aug; 217():108497. PubMed ID: 32531346
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of basal and pilocarpine-stimulated salivary flow in primary Sjögren's syndrome. Correlation with clinical, immunological and histological features.
Rosas J; Ramos-Casals M; Ena J; García-Carrasco M; Verdu J; Cervera R; Font J; Caballero O; Ingelmo M; Pascual E
Rheumatology (Oxford); 2002 Jun; 41(6):670-5. PubMed ID: 12048294
[TBL] [Abstract][Full Text] [Related]
9. Systemic sclerosis-associated Sjögren's syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients.
Avouac J; Sordet C; Depinay C; Ardizonne M; Vacher-Lavenu MC; Sibilia J; Kahan A; Allanore Y
Arthritis Rheum; 2006 Jul; 54(7):2243-9. PubMed ID: 16802363
[TBL] [Abstract][Full Text] [Related]
10. Lack of Conventional Acinar Cells in Parotid Salivary Gland of Patient Taking an Anti-PD-L1 Immune Checkpoint Inhibitor.
Pringle S; van der Vegt B; Wang X; van Bakelen N; Hiltermann TJN; Spijkervet FKL; Vissink A; Kroese FGM; Bootsma H
Front Oncol; 2020; 10():420. PubMed ID: 32300556
[No Abstract] [Full Text] [Related]
11. Sjögren's Syndrome as an Immune-related Adverse Event of Nivolumab Treatment for Gastric Cancer.
Higashi T; Miyamoto H; Yoshida R; Furuta Y; Nagaoka K; Naoe H; Naito H; Nakayama H; Tanaka M
Intern Med; 2020 Oct; 59(20):2499-2504. PubMed ID: 32581160
[TBL] [Abstract][Full Text] [Related]
12. Increased interleukin (IL)-7Rα expression in salivary glands of patients with primary Sjogren's syndrome is restricted to T cells and correlates with IL-7 expression, lymphocyte numbers and activity.
Bikker A; Kruize AA; Wenting M; Versnel MA; Bijlsma JW; Lafeber FP; van Roon JA
Ann Rheum Dis; 2012 Jun; 71(6):1027-33. PubMed ID: 22312161
[TBL] [Abstract][Full Text] [Related]
13. [Labial salivary gland biopsy in Sjögren's syndrome].
Dankof A; Morawietz L; Feist E
Pathologe; 2006 Nov; 27(6):416-21. PubMed ID: 17039338
[TBL] [Abstract][Full Text] [Related]
14. Gougerot-Sjogren-like syndrome under PD-1 inhibitor treatment.
Teyssonneau D; Cousin S; Italiano A
Ann Oncol; 2017 Dec; 28(12):3108. PubMed ID: 29045656
[No Abstract] [Full Text] [Related]
15. True primary Sjögren's syndrome in a subset of patients with hepatitis C infection: a model linking chronic infection to chronic sialadenitis.
De Vita S; Damato R; De Marchi G; Sacco S; Ferraccioli G
Isr Med Assoc J; 2002 Dec; 4(12):1101-5. PubMed ID: 12516900
[TBL] [Abstract][Full Text] [Related]
16. Salivary gland ultrasound in the diagnostic workup of juvenile Sjögren's syndrome and mixed connective tissue disease.
Krumrey-Langkammerer M; Haas JP
Pediatr Rheumatol Online J; 2020 Jun; 18(1):44. PubMed ID: 32517804
[TBL] [Abstract][Full Text] [Related]
17. Checkpoint inhibition-induced sicca: a type II interferonopathy?
Pringle S; Wang X; Vissink A; Bootsma H; Kroese FGM
Clin Exp Rheumatol; 2020; 38 Suppl 126(4):253-260. PubMed ID: 33025881
[TBL] [Abstract][Full Text] [Related]
18. Sjögren's syndrome in systemic lupus erythematosus.
Andonopoulos AP; Skopouli FN; Dimou GS; Drosos AA; Moutsopoulos HM
J Rheumatol; 1990 Feb; 17(2):201-4. PubMed ID: 2319519
[TBL] [Abstract][Full Text] [Related]
19. Profiling Autoantibodies against Salivary Proteins in Sicca Conditions.
Burbelo PD; Ferré EMN; Chaturvedi A; Chiorini JA; Alevizos I; Lionakis MS; Warner BM
J Dent Res; 2019 Jul; 98(7):772-778. PubMed ID: 31095438
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of subclinical Sjögren's syndrome features in patients with autoimmune thyroid disease.
Coll J; Anglada J; Tomas S; Reth P; Goday A; Millan M; Pujol-Borrell R; Corominas J
J Rheumatol; 1997 Sep; 24(9):1719-24. PubMed ID: 9292794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
